About Immune IQ
Immune IQ is a company based in Minneapolis (United States) founded in 2008 by David Deetz and Barbara Roth. Immune IQ has raised $54.99 million across 7 funding rounds from investors including LabCorp, Dian Diagnostics and Ping An Ventures. Immune IQ offers products and services including Immune Reveal and AI Decoding Engine. Immune IQ operates in a competitive market with competitors including NuvoAir, QuidelOrtho, BioSerenity, ProciseDx and Neurosynaptic, among others.
- Headquarter Minneapolis, United States
- Founders David Deetz, Barbara Roth
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$54.99 M (USD)
in 7 rounds
-
Latest Funding Round
$15.86 M (USD), Series A
Jan 27, 2022
-
Investors
LabCorp
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Immune IQ
Immune IQ offers a comprehensive portfolio of products and services, including Immune Reveal and AI Decoding Engine.
AI-powered analyzer for early disease detection via immune system scanning.
System for deciphering immune data to identify diseases accurately.
Funding Insights of Immune IQ
Immune IQ has successfully raised a total of $54.99M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $15.86 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Immune IQ
Immune IQ has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, Dian Diagnostics and Ping An Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate-backed venture capital firm focused on retail tech, mobile tech, and multiple sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Immune IQ
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Immune IQ
Investment portfolio details for Immune IQ
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Immune IQ
Detailed financials for Immune IQ
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Immune Iq Comparisons
Peer comparison for Immune IQ
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Immune IQ
Immune IQ operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NuvoAir, QuidelOrtho, BioSerenity, ProciseDx and Neurosynaptic, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Clinical decision support tools for respiratory diseases are provided.
|
|
| Locked | Locked | Locked |
Provider of healthcare information services
|
|
| Locked | Locked | Locked |
Provider of smart healthcare solutions for sleep and EEG lab management
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic devices for immunoassay tests are provided to clinicians.
|
|
| Locked | Locked | Locked |
ICT-based products and solutions are developed for healthcare.
|
|
| Locked | Locked | Locked |
Remote patient monitoring software is developed for healthcare providers.
|
Detailed competitors of Immune IQ
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Immune Iq
Complete news archive for Immune IQ
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Immune IQ
Immune IQ was founded in 2008 and raised its 1st funding round 4 years after it was founded.
Immune IQ is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
David Deetz is the current CEO of Immune IQ. They have also founded this company.
Immune IQ is a funded company, having raised a total of $54.99M across 7 funding rounds to date.
Immune IQ was founded in 2008 and is based in Minneapolis, United States. A diagnostic platform focused on immune diseases is operated within the health technology sector. The Immune Reveal platform is utilized to analyze health status and disease data directly from a patients immune system. Rapid diagnosis of critical conditions is facilitated through this point-of-care approach, supporting clinical decision-making in various settings.
Immune IQ's top competitors include MedTel Healthcare, QuidelOrtho and Neurosynaptic.
Immune IQ offers Immune Reveal and AI Decoding Engine.
Immune IQ has 7 investors. Key investors include LabCorp, Dian Diagnostics, Ping An Ventures, Hermed Capital, and GIMDX.